QMS Medical Allied Services Ltd
Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]
- Market Cap ₹ 184 Cr.
- Current Price ₹ 95.0
- High / Low ₹ 122 / 71.5
- Stock P/E 14.6
- Book Value ₹ 46.5
- Dividend Yield 0.53 %
- ROCE 16.6 %
- ROE 14.4 %
- Face Value ₹ 10.0
Pros
Cons
- Promoter holding has decreased over last quarter: -5.56%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|
| 122 | 156 | 172 | |
| 104 | 130 | 145 | |
| Operating Profit | 18 | 25 | 27 |
| OPM % | 15% | 16% | 16% |
| 0 | 2 | 2 | |
| Interest | 3 | 5 | 5 |
| Depreciation | 3 | 4 | 4 |
| Profit before tax | 12 | 19 | 20 |
| Tax % | 26% | 27% | |
| 9 | 14 | 14 | |
| EPS in Rs | 4.66 | 6.26 | 6.54 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -22% |
| 1 Year: | -6% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 14% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Equity Capital | 18 | 18 |
| Reserves | 61 | 72 |
| 35 | 60 | |
| 22 | 40 | |
| Total Liabilities | 135 | 190 |
| 24 | 53 | |
| CWIP | 2 | 3 |
| Investments | 2 | 3 |
| 108 | 131 | |
| Total Assets | 135 | 190 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | |
|---|---|---|
| 1 | 20 | |
| -3 | -45 | |
| 0 | 26 | |
| Net Cash Flow | -1 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Debtor Days | 124 | 101 |
| Inventory Days | 172 | 176 |
| Days Payable | 90 | 76 |
| Cash Conversion Cycle | 205 | 202 |
| Working Capital Days | 148 | 100 |
| ROCE % | 17% |
Documents
Announcements
-
Outcome of Board Meeting
13 November 2025 - Qms Medical Allied Services Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
-
Statement of deviation(s) or variation(s) under Reg. 32
13 November 2025 - Qms Medical Allied Services Limited has informed about statement of deviation(s) or variation(s) under Reg. 32
-
Shareholders meeting
13 November 2025 - EOGM Dec 5, 2025 to approve migration from NSE EMERGE to NSE Main Board; e-voting Nov28–Dec04.
-
Analysts/Institutional Investor Meet/Con. Call Updates
12 November 2025 - QMS Medical to host Q2 & H1 FY26 earnings call on Nov 17, 2025 at 12:30 PM IST.
-
Press Release
29 October 2025 - QMS MAS acquires 76% of Saarathi Healthcare; ₹12.5 crore rights proceeds used (Oct 29, 2025).
Annual reports
Concalls
-
Aug 2025TranscriptPPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
Business Overview:[1]
QMASL does marketing and distribution of medical products and medical education services to clinics, pharma, medical companies and also to individual users. These devices are sold directly in the brand of the manufacturer and are sold under the brand name Q Devices. Company manages the distribution for other brands viz. 3M, Heine, Rossmax, etc.